ONLINE ACTIVITY - Hot Seat Discussion on GLP-1 Receptor Agonists, from ENDO 2011. Earn up to 1.5 AMA PRA Category 1 Credits^TM.  Supported by an educational grant from Novo Nordisk Inc.

ENDOCRINE SELF ASSESSMENT TOOL - Managment of T2DM Disease and Cardiovascular Risk. Earn up to 2.0 AMA PRA Category 1 Credits^TM.

WEBCAST - Individualizing Diabetes Treatment for Improved Glycemic Control and Management of Comorbidities, from ENDO 2011. Earn up to 1.75 AMA PRA Category 1 Credits™. Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. which was made possible, in part, through a collaboration Eli Lilly and Company.




WEBCAST - Diabates Diagnosis & Management 2011 Workshop, from ENDO 2011. Earn up to 7.75 AMA PRA Category 1 Credits™.  Supported by educational grants from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC; Daiichi Sankyo, Inc.; Lilly USA, LLC; and Merck & Co., Inc.

PI CME - Performance Improvement Strategies in Diabetes Care. We are pleased to announce the return of this popular PI CME initiative endorsed by The Endocrine Society. Join faculty chair Howard Baum, MD, Dallas Diabetes & Endocrine Center, in the third consecutive, complimentary PI CME initiative to improve the care of patients with type 2 diabetes. Earn up to 20 AMA PRA Category 1 Credits™ and use your data to complete ABIM’s Self-Directed PIM and earn credit for ABIM MOC. To learn more, e-mail concierge@med-iq.com, call (toll-free) 866 858 7434, or visit www.pi-iq.com/diabetes. Supported by an educational grant from Lilly USA, LLC.

ONLINE ACTIVITY - Incretins and the Big Picture in T2DM: Multiple Mechanisms to Reduce Cardiovascular Risk.  Earn up to 2.5 AMA PRA Category 1 Credits™.  Supported by an educational grant from Genentech.

MONOGRAPH - On the Brink of Change: Evolving Treatment Paradigms and GLP-1 Receptor Agonists.  Supported by an educational grant from Novo Nordisk Inc.


 

VIDEO - Clinical Decision Making Around Incretin-Based Therapies: Re-examining the Safety Data.  Earn up to 1.0 AMA PRA Category 1 Credits™.  Supported by Amylin Pharmaceuticals Inc. and Lilly USA, LLC; Bristol-Myers Squibb and AstraZeneca LP; and Novo Nordisk. Please note: you must register an account with iDOC to view and complete the online activity

WEBCAST - Challenges in the Management of T2DM: Exploring the Role of GLP-1 Receptor Agonists SOUTH Regional Web-Based Conference.  Earn up to 0.5 AMA PRA Category 1 Credits™.  Supported by an educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC.

WEBCAST - Challenges in the Management of T2DM: Exploring the Role of GLP-1 Receptor Agonists EAST Regional Web-Based Conference.  Earn up to 0.5 AMA PRA Category 1 Credits™.  Supported by an educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC.

WEBCAST - Challenges in the Management of T2DM: Exploring the Role of GLP-1 Receptor Agonists CENTRAL Regional Web-Based Conference.  Earn up to 0.75 AMA PRA Category 1 Credits™.  Supported by an educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC.

WEBCAST - Highlights and Wrap-up: Challenges in the Management of T2DM: Exploring the Role of GLP-1 Receptor Agonists.  Earn up to 1.0 AMA PRA Category 1 Credits™.  Supported by an educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC.

Free access for subscribers. Earn up to 1.0 AMA PRA Category 1 Credit™ for the following JCEM articles:

Approach to the Management of the Patient with Neuropathic Pain

Approach to the Obese Adolescent with New Onset Diabetes 

Approach to the Patient with New-Onset Diabetes after Transplant (NODAT)